SUBSCRIBE: Apple Podcasts | Spotify
In this episode, Dr. Morgentaler and Dr. Brandon debunk the long-standing myth linking testosterone therapy to heart attacks and strokes, highlighting flawed studies, media misinterpretations, and recent evidence confirming its cardiovascular safety.
- 00:49 – Early Research and Positive Findings: Early studies showed testosterone therapy reduced mortality and was linked to better heart health.
- 02:17 – The 2013 JAMA Study Controversy: A 2013 JAMA study falsely claimed testosterone therapy increased heart attack and stroke risks.
- 05:27 – Debunking the JAMA Study: Dr. Morgentaler exposed errors in the JAMA study, showing opposite conclusions to its claims.
- 16:32 – The Traverse Trial and Final Verdict: The 2023 Traverse Trial confirmed no increased heart risk with testosterone therapy, ending the debate.
- 27:47 – Conclusion and Final Thoughts: This episode stresses cautious trust in medical studies and celebrates the clarity from recent research.
Resources
- Vigen, R., O’Donnell, C. I., Barón, A. E., Grunwald, G. K., Maddox, T. M., Bradley, S. M., Barqawi, A., Woning, G., Wierman, M. E., Plomondon, M. E., Rumsfeld, J. S., & Ho, P. M. (2013). Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA, 310(17), 1829–1836. https://doi.org/10.1001/jama.2013.280386
- Editorial Board. (2014, February 4). Overselling testosterone, dangerously. The New York Times. https://www.nytimes.com/2014/02/05/opinion/overselling-testosterone-dangerously.html
